Vincent Hradil

Affiliations: 
Concordia University Chicago 
Area:
Physical Chemistry, Analytical Chemistry
Google:
"Vincent Hradil"
Mean distance: 8.92
 
SNBCP

Parents

Sign in to add mentor
Paul L. Houston grad student 1986-1992 Cornell
Donald H. Levy post-doc 1991-1993 Chicago
Lennard Wharton research scientist 1993-1995
 (Staff Engineer at Packer Engineering, Naperville, IL)

Collaborators

Sign in to add collaborator
Chih-Liang Chin collaborator (Neurotree)
Daniel A. Llano collaborator (Neurotree)
Steve McGaraughty collaborator (Neurotree)
Nathan R. Rustay collaborator (Neurotree)
Benjamin J Whitaker collaborator
Lennard Wharton collaborator 1993-1995
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Luo Y, Jiang F, Cole TB, et al. (2012) A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model Cancer Chemotherapy and Pharmacology. 69: 911-921
Luo F, Rustay NR, Ebert U, et al. (2012) Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiology of Aging. 33: 933-44
Luo F, Rustay NR, Seifert T, et al. (2011) Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice (Journal of Pharmacology and Experimental Therapeutics (2010) 335, (580-588)) Journal of Pharmacology and Experimental Therapeutics. 336: 586
Luo F, Rustay NR, Seifert T, et al. (2010) Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 335: 580-8
Luo F, Chandran P, Rustay N, et al. (2010) P3-238: Latrepirdine increases cerebral glucose utilization in aged mice Alzheimer's & Dementia. 6: S521-S521
Luo Y, Hradil VP, Frost DJ, et al. (2009) ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature Anti-Cancer Drugs. 20: 483-492
Chin CL, Pai M, Bousquet PF, et al. (2009) Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. Journal of Neuroimmunology. 211: 49-55
Yao BB, Hsieh G, Daza AV, et al. (2009) Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. The Journal of Pharmacology and Experimental Therapeutics. 328: 141-51
Liu X, Shi Y, Guan R, et al. (2008) Potentiation of temozolomide cytotoxicity by poly(ADP)ribose polymerase inhibitor ABT-888 requires a conversion of single-stranded DNA damages to double-stranded DNA breaks Molecular Cancer Research. 6: 1621-1629
Luo F, Seifert TR, Edalji R, et al. (2008) Non-invasive characterization of β-amyloid1-40 vasoactivity by functional magnetic resonance imaging in mice Neuroscience. 155: 263-269
See more...